A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 23, 2013

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Localized Stage I-III Esophageal CancerGastroesophageal Junction Cancer
Interventions
OTHER

nutritional and functional assessments

"Patients will undergo nutritional \& functional assessments along the continuum of their chemoradiotherapy treatment. The initial assessment will be measurements of height, weight, \& baseline weight loss. Patients will receive chemotherapy \& radiation as per standard practice at MSKCC, which is induction chemotherapy for approximately 3 weeks, followed by concurrent chemoradiotherapy. A commonly used regimen is weekly carboplatin (AUC 2) with paclitaxel (50 mg/m2) \& radiation consisting of 5040 cGy over 28 fractions. Patients in this study will undergo assessments at three time points (at baseline, after induction chemotherapy, \& post-treatment.) At baseline, all patients will complete the functional assessment, dysphagia scale, \& Mini- Nutritional Assessment (MNA). According to the baseline MNA score, patients will be categorized as normal nutrition, at risk for malnutrition, or malnourished \& receive the appropriate intervention."

Trial Locations (7)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering West Harrison (Consent Only), Harrison

11725

Memorial Sloan Kettering Cancer Center @ Suffolk (Consent Only), Commack

Memorial Sloan Kettering Cancer Center at Commack (Consent Only), Commack

Unknown

Memorial Sloan Kettering Cancer Center at Basking Ridge (Consent Only), Basking Ridge

07748

Memorial Sloan Kettering Monmouth (Consent Only), Middletown

07645

Memorial Sloan Kettering Bergen (Consent only), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02027948 - A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer | Biotech Hunter | Biotech Hunter